142 related articles for article (PubMed ID: 31653163)
21. WT1 Expression in Adult Acute Myeloid Leukemia: Assessing its Presence, Magnitude and Temporal Changes as Prognostic Factors.
Ujj Z; Buglyó G; Udvardy M; Beyer D; Vargha G; Biró S; Rejtő L
Pathol Oncol Res; 2016 Jan; 22(1):217-21. PubMed ID: 26531831
[TBL] [Abstract][Full Text] [Related]
22. Reduced protocadherin17 expression in leukemia stem cells: the clinical and biological effect in acute myeloid leukemia.
Xu ZJ; Ma JC; Zhou JD; Wen XM; Yao DM; Zhang W; Ji RB; Wu DH; Tang LJ; Deng ZQ; Qian J; Lin J
J Transl Med; 2019 Mar; 17(1):102. PubMed ID: 30922328
[TBL] [Abstract][Full Text] [Related]
23. Identification of novel molecular markers for prognosis estimation of acute myeloid leukemia: over-expression of PDCD7, FIS1 and Ang2 may indicate poor prognosis in pretreatment patients with acute myeloid leukemia.
Tian Y; Huang Z; Wang Z; Yin C; Zhou L; Zhang L; Huang K; Zhou H; Jiang X; Li J; Liao L; Yang M; Meng F
PLoS One; 2014; 9(1):e84150. PubMed ID: 24416201
[TBL] [Abstract][Full Text] [Related]
24. Characterization of purine-rich element binding protein B as a novel biomarker in acute myelogenous leukemia prognostication.
Kelm RJ; Lamba GS; Levis JE; Holmes CE
J Cell Biochem; 2018 Feb; 119(2):2073-2083. PubMed ID: 28834593
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of HHEX in Acute Myeloid Leukemia with t(8;21)(q22;q22) Translocation.
Zhang S; Ma L; Chen Y; Xu H; Chen S; Wu W
Ann Clin Lab Sci; 2017 Nov; 47(6):687-697. PubMed ID: 29263042
[TBL] [Abstract][Full Text] [Related]
26. Chemotherapeutic Resistance in Egyptian Acute Myeloid Leukemia Patients.
Kassem NM; Medhat N; Kassem HA; El-Desouky MA
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2421-2427. PubMed ID: 31450916
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of CEBPA mutations and BAALC expression in acute myeloid leukemia Egyptian patients with normal karyotype.
El-Sharnouby JA; Ahmed LM; Taha AM; Kamal O
Egypt J Immunol; 2008; 15(1):131-43. PubMed ID: 20306678
[TBL] [Abstract][Full Text] [Related]
28. Tim-3 is highly expressed in T cells in acute myeloid leukemia and associated with clinicopathological prognostic stratification.
Li C; Chen X; Yu X; Zhu Y; Ma C; Xia R; Ma J; Gu C; Ye L; Wu D
Int J Clin Exp Pathol; 2014; 7(10):6880-8. PubMed ID: 25400771
[TBL] [Abstract][Full Text] [Related]
29. Methylation-associated DOK1 and DOK2 down-regulation: Potential biomarkers for predicting adverse prognosis in acute myeloid leukemia.
He PF; Xu ZJ; Zhou JD; Li XX; Zhang W; Wu DH; Zhang ZH; Lian XY; Yao XY; Deng ZQ; Lin J; Qian J
J Cell Physiol; 2018 Sep; 233(9):6604-6614. PubMed ID: 29150948
[TBL] [Abstract][Full Text] [Related]
30. Circ-Foxo3 is positively associated with the Foxo3 gene and leads to better prognosis of acute myeloid leukemia patients.
Zhou J; Zhou LY; Tang X; Zhang J; Zhai LL; Yi YY; Yi J; Lin J; Qian J; Deng ZQ
BMC Cancer; 2019 Sep; 19(1):930. PubMed ID: 31533653
[TBL] [Abstract][Full Text] [Related]
31. Investigation of the Osteopontin isoforms expression in patients with acute myeloid leukemia.
Ferdowsi S; Ghaffari SH; Shiraji ST; Mousavi SA; Mohammadi S
Med Oncol; 2021 Jul; 38(9):102. PubMed ID: 34313836
[TBL] [Abstract][Full Text] [Related]
32. Identification of new markers discriminating between myeloid and lymphoid acute leukemia.
Haouas H; Haouas S; Uzan G; Hafsia A
Hematology; 2010 Aug; 15(4):193-203. PubMed ID: 20670477
[TBL] [Abstract][Full Text] [Related]
33. SALL4, a stem cell factor, affects the side population by regulation of the ATP-binding cassette drug transport genes.
Jeong HW; Cui W; Yang Y; Lu J; He J; Li A; Song D; Guo Y; Liu BH; Chai L
PLoS One; 2011 Apr; 6(4):e18372. PubMed ID: 21526180
[TBL] [Abstract][Full Text] [Related]
34. Secretion and Expression of Matrix Metalloproteinase-2 and 9 from Bone Marrow Mononuclear Cells in Myelodysplastic Syndrome and Acute Myeloid Leukemia.
Chaudhary AK; Chaudhary S; Ghosh K; Shanmukaiah C; Nadkarni AH
Asian Pac J Cancer Prev; 2016; 17(3):1519-29. PubMed ID: 27039800
[TBL] [Abstract][Full Text] [Related]
35. [Expression of PRAME gene in acute leukemia and its clinical significance].
Zhu YL; Liu J; Zhu P; DU JW; Zhang Y; Gu JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Dec; 15(6):1144-9. PubMed ID: 18088454
[TBL] [Abstract][Full Text] [Related]
36. Hypoxia-Inducible Factor1-Α (HIF1α) and Vascular Endothelial Growth Factor-A (VEGF-A) Expression in De Novo AML Patients.
Jabari M; Allahbakhshian Farsani M; Salari S; Hamidpour M; Amiri V; Mohammadi MH
Asian Pac J Cancer Prev; 2019 Mar; 20(3):705-710. PubMed ID: 30909668
[TBL] [Abstract][Full Text] [Related]
37. Expression of PIM-2 and NF-κB genes is increased in patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) and is associated with complete remission rate and overall survival.
Kapelko-Słowik K; Urbaniak-Kujda D; Wołowiec D; Jaźwiec B; Dybko J; Jakubaszko J; Słowik M; Kuliczkowski K
Postepy Hig Med Dosw (Online); 2013 Jun; 67():553-9. PubMed ID: 23752607
[TBL] [Abstract][Full Text] [Related]
38. The implication of lncRNA expression pattern and potential function of lncRNA RP4-576H24.2 in acute myeloid leukemia.
Zheng J; Song Y; Li Z; Tang A; Fei Y; He W
Cancer Med; 2019 Dec; 8(17):7143-7160. PubMed ID: 31568697
[TBL] [Abstract][Full Text] [Related]
39. High expression of lnc-CRNDE presents as a biomarker for acute myeloid leukemia and promotes the malignant progression in acute myeloid leukemia cell line U937.
Wang Y; Zhou Q; Ma JJ
Eur Rev Med Pharmacol Sci; 2018 Feb; 22(3):763-770. PubMed ID: 29461608
[TBL] [Abstract][Full Text] [Related]
40. PIM-1 mRNA expression is a potential prognostic biomarker in acute myeloid leukemia.
Cheng H; Huang C; Xu X; Hu X; Gong S; Tang G; Song X; Zhang W; Wang J; Chen L; Yang J
J Transl Med; 2017 Aug; 15(1):179. PubMed ID: 28851457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
